Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rullmann

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSvenja Schwarck, Niklas Behrenbruch, Beate Schumann-Werner, et al.
Neuroscience and Biobehavioral Reviews|March 7, 2026
Molecular connectivity studies of cerebral glucose metabolism and blood flow: a scoping reviewCarlo Cavaliere, Alice Galli, Chiara Meneghini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2026
Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [<sup>18</sup>F]PI-2620 PETJohannes Gnörich, Julia Kusche-Palenga, Carla Palleis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsyMengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2022
Additive value of [<sup>18</sup>F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndromeSabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
Brain : a Journal of Neurology|August 14, 2025
Connectivity as a universal predictor of tau progression in atypical Alzheimer's diseaseHannah de Bruin, Colin Groot, Henryk Barthel, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSvenja Schwarck, Niklas Behrenbruch, Beate Schumann-Werner, et al.
Neuroscience and Biobehavioral Reviews|March 7, 2026
Molecular connectivity studies of cerebral glucose metabolism and blood flow: a scoping reviewCarlo Cavaliere, Alice Galli, Chiara Meneghini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2026
Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [<sup>18</sup>F]PI-2620 PETJohannes Gnörich, Julia Kusche-Palenga, Carla Palleis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsyMengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2022
Additive value of [<sup>18</sup>F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndromeSabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
Brain : a Journal of Neurology|August 14, 2025
Connectivity as a universal predictor of tau progression in atypical Alzheimer's diseaseHannah de Bruin, Colin Groot, Henryk Barthel, et al.
Pageof 9